Pages that link to "Q72858691"
Jump to navigation
Jump to search
The following pages link to The use of aminoglutethimide in the treatment of patients with metastatic carcinoma of the breast (Q72858691):
Displaying 11 items.
- Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial (Q34785202) (← links)
- Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer (Q36684234) (← links)
- Anastrozole Use in Early Stage Breast Cancer of Post-Menopausal Women (Q37366511) (← links)
- Endocrine therapy of metastatic breast cancer (Q38363146) (← links)
- Aromatase in breast cancer and the role of aminoglutethimide and other aromatase inhibitors (Q39591378) (← links)
- Could aminoglutethimide replace adrenalectomy? (Q39840475) (← links)
- Suppression of estrogens with Aminoglutethimide and hydrocortisone (medical adrenalectomy) as treatment of advanced breast carcinoma: A review (Q40132276) (← links)
- Modulation of natural killer cell activity in stage I postmenopausal breast cancer patients on low-dose aminoglutethimide (Q43778496) (← links)
- Oral high-dose medroxyprogesterone acetate causes adrenal suppression in patients with breast cancer (Q67266073) (← links)
- Clinical pharmacology of aminoglutethimide in patients with metastatic breast cancer (Q69466570) (← links)
- Estrogen Receptor Status and the Clinical Response to a Combination of Aminoglutethimide and Cortisol in Advanced Breast Cancer (Q72734360) (← links)